I agree OWCP isn't at GWPH's level now, but years away? What about our first product launch here being months away? What about if the PTSD, Multiple Myeloma, and/or Migraine meds possibly being closer to launch later in the year?
More delivery system options...
I think we COULD be quickly approaching a GWPH comparison later in the year. Whether we catch their $3B value is another thing. After all, they do have a lot more cash in the bank currently.. But we have more of a product pipeline possibility from what I see.
Thoughts?